Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03080005 14,15-EET cPLA2i 1.0 BCD110605C28 0.311 pmol/ml medium
LMFA03080005 14,15-EET cPLA2i 1.0 BCD110605C30 0.354 pmol/ml medium
LMFA03080005 14,15-EET cPLA2i 1.0 BCD110605C29 0.334 pmol/ml medium
LMFA03080005 14,15-EET cPLA2i 20.0 BCD110605C64 0.809 pmol/ml medium
LMFA03080005 14,15-EET cPLA2i 20.0 BCD110605C66 0.826 pmol/ml medium
LMFA03080005 14,15-EET cPLA2i 20.0 BCD110605C65 0.802 pmol/ml medium
LMFA03080005 14,15-EET PLDi 1.0 BCD110605C16 0.298 pmol/ml medium
LMFA03080005 14,15-EET PLDi 1.0 BCD110605C17 0.296 pmol/ml medium
LMFA03080005 14,15-EET PLDi 1.0 BCD110605C18 0.326 pmol/ml medium
LMFA03080005 14,15-EET PLDi 20.0 BCD110605C54 1.03 pmol/ml medium
LMFA03080005 14,15-EET PLDi 20.0 BCD110605C52 1.07 pmol/ml medium
LMFA03080005 14,15-EET PLDi 20.0 BCD110605C53 1.17 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 1.0 BCD110605C32 0.319 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 1.0 BCD110605C31 0.326 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 1.0 BCD110605C33 0.343 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 20.0 BCD110605C68 0.638 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 20.0 BCD110605C69 0.6 pmol/ml medium
LMFA03080005 14,15-EET KDO+cPLA2i 20.0 BCD110605C67 0.653 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 1.0 BCD110605C19 0.301 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 1.0 BCD110605C20 0.289 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 1.0 BCD110605C21 0.326 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 20.0 BCD110605C56 0.677 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 20.0 BCD110605C57 0.715 pmol/ml medium
LMFA03080005 14,15-EET KDO+PLDi 20.0 BCD110605C55 0.689 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 1.0 BCD110605C37 0.371 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 1.0 BCD110605C38 0.297 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 1.0 BCD110605C39 0.359 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 20.0 BCD110605C74 0.256 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 20.0 BCD110605C75 0.273 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+cPLA2i 20.0 BCD110605C73 0.251 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 1.0 BCD110605C25 0.402 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 1.0 BCD110605C27 0.363 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 1.0 BCD110605C26 0.377 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 20.0 BCD110605C61 0.273 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 20.0 BCD110605C62 0.239 pmol/ml medium
LMFA03080005 14,15-EET KDO+ATP+PLDi 20.0 BCD110605C63 0.185 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 1.0 BCD110605C15 0.322 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 1.0 BCD110605C14 0.364 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 1.0 BCD110605C13 0.28 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 20.0 BCD110605C49 0.297 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 20.0 BCD110605C50 0.294 pmol/ml medium
LMFA03080005 14,15-EET KDO + ATP 20.0 BCD110605C51 0.259 pmol/ml medium
LMFA03080005 14,15-EET KDO 1.0 BCD110605C08 0.317 pmol/ml medium
LMFA03080005 14,15-EET KDO 1.0 BCD110605C07 0.314 pmol/ml medium
LMFA03080005 14,15-EET KDO 1.0 BCD110605C09 0.357 pmol/ml medium
LMFA03080005 14,15-EET KDO 20.0 BCD110605C45 0.788 pmol/ml medium
LMFA03080005 14,15-EET KDO 20.0 BCD110605C44 0.776 pmol/ml medium
LMFA03080005 14,15-EET KDO 20.0 BCD110605C43 0.795 pmol/ml medium
LMFA03080005 14,15-EET C 0.0 BCD110605C03 0.356 pmol/ml medium
LMFA03080005 14,15-EET C 0.0 BCD110605C01 0.289 pmol/ml medium